6295-93-8

Basic information

• Product Name: 2-(diphenylamino)-1H-isoindole-1,3(2H)-dione
• CAS NO: 6295-93-8
• Molecular Formula: C₂₀H₁₄N₂O₂
• Molecular Weight: 314.3374
• Mol File: 6295-93-8.mol

Chemical Properties

• Boiling Point: 483.8°C at 760 mmHg
• Flash Point: 218.3°C
• Density: 1.351g/cm³
• Vapor Pressure: 1.63E-09mmHg at 25°C
• Refractive Index: 1.714
• CAS DataBase Reference: 2-(diphenylamino)-1H-isoindole-1,3(2H)-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(diphenylamino)-1H-isoindole-1,3(2H)-dione(6295-93-8)
• EPA Substance Registry System: 2-(diphenylamino)-1H-isoindole-1,3(2H)-dione(6295-93-8)

Safety Data

• Hazardous Substances Data: 6295-93-8(Hazardous Substances Data)

Usage

Uses

Used in Dye and Ink Manufacturing:
2-(diphenylamino)-1H-isoindole-1,3(2H)-dione is utilized as a pigment in the production of dyes and inks, capitalizing on its color-producing properties to create a wide range of hues for various industries.
Used in Organic Synthesis and Materials Science:
In the realm of organic synthesis and materials science, 2-(diphenylamino)-1H-isoindole-1,3(2H)-dione is employed as a building block for the development of new materials and compounds, leveraging its unique structural and chemical characteristics.
Used in Medical Applications:
2-(diphenylamino)-1H-isoindole-1,3(2H)-dione has potential applications in the medical field, where it is explored for its ability to inhibit specific enzymes and biological processes, offering a promising avenue for the development of new therapeutic agents.

Upstream product

• 4870-16-0 N-anilinophthalimide 
• 603-33-8 triphenylbismuthane 
• 85-44-9 phthalic anhydride 
• 530-47-2 N,N-diphenylhydrazine hydrochloride 
• 524-38-9 N-hydroxyphthalimide 

Downstream Products

• 530-50-7 1,1-Diphenylhydrazine 
• 32228-99-2 4-phenyldiphenylamine 
• 86-74-8 9H-carbazole 

Relevant articles and documents

INHIBITORS OF IRES-MEDIATED PROTEIN SYNTHESIS

This disclosure relates to inhibitors of IRES-mediated protein synthesis, compositions comprising therapeutically effective amounts of these compounds, and methods of using those compounds and compositions in treating hyperproliferative disorders, e.g., cancers. This disclosure also relates to compositions comprising inhibitors of IRES-mediated protein synthesis and mTOR inhibitors, and to methods of treating cancer by conjoint administration of inhibitors of IRES-mediated protein synthesis and mTOR inhibitors.

N-phenylation of N-arylaminophthalimides with triphenylbismuth and cupric acetate: A convenient synthesis of 1-aryl-1-phenylhydrazines

Synthesis of 1-aryl-1-phenylhydrazines (2) from N-aryl-N- phenylaminophthalimides (1) which were synthesized by the phenylation of 1 with triphenylbismuth and cupric acetate is described.

Synthesis of hole-transporting hydrazone dendrimers

Hole-transporting aromatic hydrazone dendrimers were synthesized by convergent method. Structures of dendrimers were characterized by NMR, IR, GC/MS (FAB+), and elemental analysis.